Buy & Sell Marsh & McLennan Companies, Inc. (MRSH) – Marsh & McLennan Companies, Inc. Price Today
Aura AI Summary
Key Stats
- $77.69BMarket Cap
- FinancialsSector
- -14.07%3M Drawdown
- $98.53BEnterprise Value
- 2.23%Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 101 daysTypical Hold Time
Marsh & McLennan Companies, Inc. (MRSH) is currently valued at a market capitalization of $77.69B, with an enterprise value of $98.53B. Over the past 52 weeks, Marsh & McLennan Companies, Inc. has traded between a low of $157.32 and a high of $230.01, highlighting its annual price range. Over the past three months, Marsh & McLennan Companies, Inc. has recorded a drawdown of -14.07%, reflecting recent price volatility. Marsh & McLennan Companies, Inc. offers a dividend yield of 2.23%, with the most recent dividend of $0.90 paid on 09 Apr 26. On average, investors hold Marsh & McLennan Companies, Inc. for approximately 101 days, indicating typical investor behavior on the platform.
About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Most Recent News
BlackRock surpasses 5% ownership in Finnish pharma company Orion Oyj
BlackRock, Inc. has officially notified that its direct and indirect ownership in Orion Oyj, a Finnish pharmaceutical company, has exceeded the 5% threshold as of June 4, 2026. This includes shares held directly, indirectly, and through financial ins...

DIAGNOS nears key regulatory approvals for AI eye disease detection platform CARA, expanding market potential.
DIAGNOS inc. is advancing toward important regulatory approvals for its AI-powered eye disease detection platform, CARA, with submissions underway in Canada, the US, and Saudi Arabia. The platform has already assessed over 400,000 patients globally a...

SpaceX's AI unit lost $6.4B in 2025 as it invests in massive AI infrastructure for future growth.
SpaceX's AI business reported a $6.4 billion operating loss in 2025, up from a $1.6 billion loss the previous year, reflecting heavy investment in AI compute infrastructure and growth initiatives. The company has deployed AI training clusters with ov...
